Development, reliability, and validity of a new preference and satisfaction questionnaire

Value in Health

Volumn 14, Issue 8, 2011, Pages 1109-1116

  Gold, Deborah T ^a   Horne, Rob ^b   Coon, Cheryl D ^c   Price, Mark A ^c   Borenstein, Jeff ^d   Varon, Sepideh F ^e   Satram Hoang, Sacha ^d   MacArios, David ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RTI HEALTH SOLUTIONS   (United States)

^d AMGEN INC   (United States)

^e ALLERGAN INC   (United States)

Author keywords

preference; questionnaire development; reliability; satisfaction; validation

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB;

ARTICLE; CONTENT VALIDITY; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT ANALYSIS; FACTORIAL ANALYSIS; HUMAN; INTERVIEW; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL (TOPIC); PILL; POSTMENOPAUSE OSTEOPOROSIS; PREFERENCE AND SATISFACTION QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SCORING SYSTEM; TABLET; VALIDITY;

AGED; ALENDRONATE; ANTIBODIES, MONOCLONAL; BONE DENSITY CONSERVATION AGENTS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT PREFERENCE; PATIENT SATISFACTION; PILOT PROJECTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 82955168382     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.06.010     Document Type: Article

References (44)

1. C. Cooper Epidemiology of osteoporosis Osteoporos Int 9 Suppl. 2 1999 S2 S8
2. L.J. Melton 3rd, E.A. Chrischilles, C. Cooper Perspective How many women have osteoporosis? J Bone Miner Res 7 1992 1005 1010
3. P. Kothawala, E. Badamgarav, S. Ryu Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 2007 1493 1501 (Pubitemid 350211697)
4. J.Y. Reginster, V. Rabenda, A. Neuprez Adherence, patient preference and dosing frequency: understanding the relationship Bone 38 Suppl. 2006 S2 S6
5. E.S. Siris, S.T. Harris, C.J. Rosen Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 2006 1013 1022 (Pubitemid 44175011)
6. J. Payer, Z. Killinger, I. Sulkova Preferences of patients receiving bisphosphonateshow to influence the therapeutic adherence Biomed Pharmacother 62 2008 122 124 (Pubitemid 351215813)
7. E. Lau, A. Papaioannou, L. Dolovich Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women Can Fam Physician 54 2008 394 402 (Pubitemid 351413664)
8. C.A. McHorney, J.T. Schousboe, R.R. Cline The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates Curr Med Res Opin 23 2007 3137 3152
9. E. Barrett-Connor, S. Wade, T. Do Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US Osteoporos Int 2011 Apr 6 [Epub ahead of print]
10. J.P. Brown, R.L. Prince, C. Deal Comparison of the effect of denosumab and alendronate on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial J Bone Miner Res 24 2009 153 161
11. D.L. Kendler, C. Roux, C.L. Benhamou Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy J Bone Miner Res 25 2010 72 81
12. S.R. Cummings, J. San Martin, M.R. McClung Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 2009 756 765
13. L. Fallowfield, L. Atkins, S. Catt Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer Ann Oncol 17 2006 205 210 (Pubitemid 43160107)
14. D.T. Gold, W. Safi, H. Trinh Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate Curr Med Res Opin 22 2006 2383 2391 (Pubitemid 46055201)
15. A.L. Granger, S.E. Fehnel, S.L. Hogue An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey J Affect Disord 90 2006 217 221 (Pubitemid 43183531)
16. M.F. Drummond, M.J. Sculpher, G.W. Torrance Methods for the Economic Evaluation of Health Care Programmes 3rd ed. 2005 Oxford University Press New York
17. R.L. Kravitz Patients' expectations for medical care: an expanded formulation based on review of the literature Med Care Res Rev 53 1996 3 27 (Pubitemid 126722725)
18. M. Weaver, D.L. Patrick, L.E. Markson Issues in the measurement of satisfaction with treatment Am J Manag Care 3 1997 579 594 (Pubitemid 127528785)
19. P. Cram, J. Schlechte, G.E. Rosenthal Patient preference for being informed of their DXA scan results J Clin Densitom 7 2004 275 280 (Pubitemid 39178895)
20. R. Emkey, W. Koltun, K. Beusterien Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO) Curr Med Res Opin 21 2005 1895 1903 (Pubitemid 41803098)
21. D. Kendler, A.W. Kung, H. Fuleihan Gel Patients with osteoporosis prefer once weekly to once daily dosing with alendronate Maturitas 48 2004 243 251 (Pubitemid 38781149)
22. S. Rozenberg, H. Ham Effect of physicians opinion on patients' choice of treatment Eur J Obstet Gynecol Reprod Biol 96 2001 215 217 (Pubitemid 32522564)
23. J.A. Simon, E.M. Lewiecki, M.E. Smith Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study Clin Ther 24 2002 1871 1886 (Pubitemid 35440956)
24. C. Turbi, G. Herrero-Beaumont, J.C. Acebes Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study Clin Ther 26 2004 245 256 (Pubitemid 38339016)
25. C.G. Unson, E. Siccion, J. Gaztambide Nonadherence and osteoporosis treatment preferences of older women: a qualitative study J Womens Health (Larchmnt) 12 2003 1037 1045 (Pubitemid 38072422)
26. M. Weiss, I. Vered, A.J. Foldes Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study Aging Clin Exp Res 17 2005 143 149 (Pubitemid 41558123)
27. T.W. Weiss, D.T. Gold, S.L. Silverman An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study Curr Med Res Opin 22 2006 949 960 (Pubitemid 43875562)
28. K. Gruffydd-Jones, C.A. Hood, D.B. Price A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice Cephalalgia 17 1997 31 36 (Pubitemid 27101418)
29. J. Schoenen, J. Pascual, S. Rasmussen Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan Eur J Neurol 12 2005 108 117 (Pubitemid 40260729)
30. D.E. Fosnocht, M.B. Hollifield, E.R. Swanson Patient preference for route of pain medication delivery J Emerg Med 26 2004 7 11 (Pubitemid 38147515)
31. L.P. Shulman, M. Oleen-Burkey, R.J. Willke Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) Contraception 60 1999 215 222 (Pubitemid 30017816)
32. D. Wild, A. Grove, M. Martin Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation Value Health 8 2005 94 104 (Pubitemid 40525371)
33. H. Kaiser The application of electronic computers to factor analysis Educ Psychol Measure 20 1960 141 151
34. R.B. Cattell The scree test for the number of factors Multivar Behav Res 1 1966 245 267
35. K.G. Jöreskog, D. Sörbom LISREL® 8.8 2006 Scientific Software International, Inc. Lincolnwood, IL
36. K.G. Jöreskog, D. Sörbom LISREL VI: Analysis of Linear Structural Relationships by Maximum Likelihood and Least Squares Methods 1986 Scientific Software, Inc. Mooresville, IN
37. P.M. Bentler Structural Equations, Program Manual, Program Version 3.0 1989 BMDP Statistical Software, Inc. Los Angeles
38. L.R. Tucker, C. Lewis A reliability coefficient for maximum likelihood factor analysis Psychometrika 38 1973 1 10
39. L. Cronbach Coefficient alpha and the internal structure of tests Psychometrika 16 1951 294 330
40. D.L. Streiner, G.R. Norman Health Measurement Scales: A Practical Guide to their Development and Use 2nd ed. 1995 Oxford University Press New York
41. D.L. Kendler, L. Bessette, C.D. Hill Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass Osteoporos Int 21 2010 837 846
42. D.F. Cella, I. Wiklund, S.A. Shumaker Integrating health-related quality of life into cross-national clinical trials Qual Life Res 2 1993 433 440 (Pubitemid 24035215)
43. L. Grigoryan, J.G. Burgerhof, J.E. Degener Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study Pharmacoepidemiol Drug Saf 16 2007 1234 1243 (Pubitemid 350120649)
44. L. Radbruch, R. Sabatowski, F. Elsner Patients' associations with regard to analgesic drugs and their forms for applicationa pilot study Support Care Cancer 10 2002 480 485 (Pubitemid 36056273)